Cross-sectional study of associations between normal body weight with central obesity and hyperuricemia in Japan

• Published in: BMC endocrine disorders Vol. 20; no. 1; p. 2
• Main Authors: Shirasawa, Takako, Ochiai, Hirotaka, Yoshimoto, Takahiko, Nagahama, Satsue, Watanabe, Akihiro, Yoshida, Reika, Kokaze, Akatsuki
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 06-01-2020; BioMed Central; BMC
• Subjects: Analysis; Blood pressure; Body mass index; Body weight; Cardiovascular diseases; Confidence intervals; Cross-sectional studies; Diabetes; Diabetes mellitus; Diseases; Drinking (Alcoholic beverages); Dyslipidemia; Females; Health; Hypertension; Hyperuricemia; Male identity; Medical examination; Metabolic syndrome; Middle age; Normal weight central obesity; Obesity; Purines; Ratios; Risk factors; Statistical analysis; Studies; Substance abuse treatment; Testing laboratories; Type 2 diabetes; Uric acid; Waist-to-height ratio; Womens health; Japan; Body mass index; Hyperuricemia; Waist-to-height ratio; Normal weight central obesity
• ISSN: 1472-6823; 1472-6823
• DOI: 10.1186/s12902-019-0481-1

Several studies have shown that normal weight with central obesity (NWCO) is associated with cardiovascular disease risk factors such as hypertension, dyslipidemia and diabetes. However, the relationship between NWCO and hyperuricemia has not been studied in detail.
We investigated the association between NWCO and hyperuricemia among Japanese adults aged 40-64 years who had undergone periodic health examinations between April 2013 and March 2014. Obesity was defined as a body mass index (BMI) ≥25 kg/m
and central obesity was determined as a waist-to-height ratio (WHtR) ≥0.5. We classified the participants into the following groups based according to having obesity and central obesity: normal weight (BMI 18.5-24.9 kg/m
) without (NW; WHtR < 0.5) and with (NWCO) central obesity, and obesity without (OB) and with (OBCO) central obesity. Hyperuricemia was defined as serum uric acid > 7.0 and ≥ 6.0 mg/dL in men and women, respectively, or under medical treatment for hyperuricemia. Alcohol intake was classified as yes (daily and occasional consumption) and none (no alcohol consumption). Odds ratios (OR) and 95% confidence intervals (CI) for hyperuricemia were calculated using a logistic regression model.
We analyzed data derived from 96,863 participants (69,241 men and 27,622 women). The prevalences of hyperuricemia in men and women were respectively, 21.4 and 11.0%, and of participants with NWCO respectively 15.6 and 30.0%. The adjusted OR for hyperuricemia was significantly increased in OBCO compared with NW, regardless of sex (men: OR, 2.12; 95%CI; 2.03-2.21; women: OR, 3.54; 95%CI, 3.21-3.90) and were statistically significant in NWCO compared with NW (men: OR, 1.44; 95%CI, 1.36-1.52; women: OR, 1.41; 95%CI, 1.27-1.57). The results were similar regardless of alcohol consumption.
We found that NWCO and OBCO were associated with hyperuricemia in middle-aged Japanese men and women. Middle-aged Japanese adults with normal weight but having central obesity should be screened using a combination of BMI and WHtR and educated about how to prevent hyperuricemia.